Literature DB >> 17136338

The insulin analog glargine during an unplanned pregnancy.

Daniela Cechurová, Silvie Lacigová, Zdenĕk Jankovec, Iva Haladová, Michal Zourek, Michal Krcma, Zdenĕk Rusavý, Jirí Turek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17136338     DOI： 10.1007/s00508-006-0707-x

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  10 in total

1.  Use of insulin glargine during pregnancy in a type 1 diabetic woman.

Authors:  John T Devlin; Loretta Hothersall; J L Wilkis
Journal:  Diabetes Care       Date:  2002-06       Impact factor: 19.112

2.  Use of insulin glargine during embryogenesis in a pregnant woman with Type 1 diabetes.

Authors:  A Holstein; A Plaschke; E-H Egberts
Journal:  Diabet Med       Date:  2003-09       Impact factor: 4.359

3.  Use of insulin glargine during pregnancy in seven type 1 diabetic women.

Authors:  Jorien M Woolderink; Aren J van Loon; Fred Storms; Loek de Heide; Klaas Hoogenberg
Journal:  Diabetes Care       Date:  2005-10       Impact factor: 19.112

4.  Use of insulin glargine during the first weeks of pregnancy in five type 1 diabetic women.

Authors:  Graziano Di Cianni; Laura Volpe; Cristina Lencioni; Kyriazoula Chatzianagnostou; Ilaria Cuccuru; Alessandra Ghio; Luca Benzi; Stefano Del Prato
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

5.  Use of glargine insulin before and during pregnancy in a woman with type 1 diabetes and Addison's Disease.

Authors:  Maria Dolci; Mary Mori; Fabio Baccetti
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

6.  [Are "designer" insulins the "best" insulins?].

Authors:  Alexandra Kautzky-Willer
Journal:  Wien Klin Wochenschr       Date:  2005-09       Impact factor: 1.704

Review 7.  Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?

Authors:  A Lapolla; M G Dalfrà; D Fedele
Journal:  Diabetes Metab Res Rev       Date:  2005 May-Jun       Impact factor: 4.876

8.  Severe diabetic fetopathy despite strict metabolic control.

Authors:  Heinz Leipold; Christof Worda; Jens Schwindt; Alexandra Kautzky-Willer; Dagmar Bancher-Todesca; Peter W Husslein
Journal:  Wien Klin Wochenschr       Date:  2005-08       Impact factor: 1.704

9.  Large-for-gestational-age newborns in women with insulin-treated gestational diabetes under strict metabolic control.

Authors:  Heinz Leipold; Christof Worda; Christian J Gruber; Alexandra Kautzky-Willer; Peter W Husslein; Dagmar Bancher-Todesca
Journal:  Wien Klin Wochenschr       Date:  2005-08       Impact factor: 1.704

10.  Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits.

Authors:  Thomas Hofmann; Georg Horstmann; Ingo Stammberger
Journal:  Int J Toxicol       Date:  2002 May-Jun       Impact factor: 2.032
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.